May 8, 2018 / 11:03 AM / 7 months ago

BRIEF-Aralez Pharmaceuticals Reports Q1 Loss Per Share Of $0.29

1 分钟阅读

May 8 (Reuters) - Aralez Pharmaceuticals Inc:

* ARALEZ ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

* 1Q 2018 NET REVENUES INCREASED TO $38.1 MILLION VERSUS $26.0 MILLION IN 1Q 2017

* WITHDRAWING ITS PREVIOUS GUIDANCE

* AS OF MARCH 31, 2018 HAD CASH AND CASH EQUIVALENTS OF APPROXIMATELY $43.9 MILLION

* ARALEZ - DETERMINED THERE IS REASONABLE POSSIBILITY CO WILL NOT HAVE SUFFICIENT LIQUIDITY TO FUND CURRENT & PLANNED OPERATIONS THROUGH NEXT 12 MONTHS

* ARALEZ PHARMACEUTICALS - THERE IS SUBSTANTIAL DOUBT ABOUT COMPANY'S ABILITY TO CONTINUE AS A GOING CONCERN Source text for Eikon: Further company coverage:

我们的标准：汤森路透“信任原则”

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below